You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GCIG: Gynecologic Cancer Intergroup

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometrial Cancer Trial in Copenhagen (Palbociclib/, Letrozole)

Completed
  • Endometrial Cancer
  • Copenhagen, Sjaelland, Denmark
    NSGO-CTU
Jan 7, 2022

Ovarian Cancer Trial in Denmark, Finland, Norway (Durvalumab, Tremelilumab, MEDI 9447, MEDI 0562)

Completed
  • Ovarian Cancer
  • Durvalumab, Tremelilumab, MEDI 9447, MEDI 0562
  • Vejle, Region Syddanmark, Denmark
  • +4 more
Jan 7, 2022

Ovarian Cancer Trial in Boston, Copenhagen (Niraparib, Bevacizumab)

Completed
  • Ovarian Cancer
  • Boston, Massachusetts
  • +1 more
Jan 7, 2022

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Denmark, Norway, Sweden (KAND567, Carboplatin)

Recruiting
  • Epithelial Ovarian Cancer
  • +2 more
  • Odense, Denmark
  • +3 more
Oct 16, 2023

High Grade Serous Adenocarcinoma of Ovary, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial (Sovilnesib)

Not yet recruiting
  • High Grade Serous Adenocarcinoma of Ovary
  • +3 more
  • (no location specified)
Oct 13, 2023

Serous Ovarian Cancer, Advanced Ovarian Cancer Trial (SC0191, Gemcitabine, Paclitaxel)

Not yet recruiting
  • Serous Ovarian Cancer
  • Advanced Ovarian Cancer
  • (no location specified)
Sep 20, 2023

Ovarian Cancer, Peritoneal Carcinomatosis, Fallopian Tube Cancer Trial in Newport Beach, Orlando (GL-ONC1 alone, or in

Completed
  • Ovarian Cancer
  • +2 more
  • GL-ONC1 alone, or in combination with chemotherapy with or without bevacizumab
  • Newport Beach, California
  • +1 more
Jan 3, 2023

Epithelial Ovarian Carcinoma Stage III, Epithelial Ovarian Carcinoma Stage IV, Fallopian Tube Carcinoma Stage III Trial in China

Recruiting
  • Epithelial Ovarian Carcinoma Stage III
  • +5 more
  • nab-paclitaxel combined with carboplatin
  • Guangzhou, Guangdong, China
  • +10 more
Feb 19, 2023

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Worldwide (tisotumab vedotin)

Completed
  • Ovarian Cancer
  • +2 more
  • tisotumab vedotin
  • San Jose, California
  • +36 more
Jul 8, 2022

Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer Trial (VLS-1488)

Not yet recruiting
  • Advanced Solid Tumor
  • +15 more
  • (no location specified)
Jun 2, 2023

Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Canada, United States (Nemvaleukin

Recruiting
  • Platinum-resistant Ovarian Cancer
  • +2 more
  • Nemvaleukin and Pembrolizumab Combination
  • +6 more
  • Ventura, California
  • +7 more
Aug 5, 2022

Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab Soravtansine)

Completed
  • Epithelial Ovarian Cancer
  • +2 more
  • Mirvetuximab Soravtansine
  • Phoenix, Arizona
  • +88 more
Jan 19, 2023

Ovarian Carcinoma Trial (PEP-DC1, OC-DC, PEP-DC2)

Not yet recruiting
  • Ovarian Carcinoma
  • PEP-DC1
  • +3 more
  • (no location specified)
Jan 26, 2023

Ovarian Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma Trial in Canada, Singapore, United States

Active, not recruiting
  • Ovarian Brenner Tumor
  • +11 more
  • Duarte, California
  • +15 more
Aug 11, 2022

Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial (HS-10502)

Not yet recruiting
  • Ovarian Cancer
  • +4 more
  • (no location specified)
Feb 24, 2023

Endometrial Cancer Trial in Worldwide (Data collection)

Recruiting
  • Endometrial Cancer
  • Data collection
  • Stanford, California
  • +18 more
Oct 12, 2021

Ovarian Epithelial Carcinoma Trial in Los Angeles (PD0332991)

Completed
  • Ovarian Epithelial Carcinoma
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Jun 3, 2020

Acute Myeloid Leukemia, MDS, Glioblastoma Multiforme Trial in United States (DSP-7888 Dosing Emulsion)

Completed
  • Acute Myeloid Leukemia
  • +8 more
  • DSP-7888 Dosing Emulsion
  • Denver, Colorado
  • +7 more
Apr 4, 2022

Ovarian Cancer Trial in United States (Magrolimab, Avelumab)

Completed
  • Ovarian Cancer
  • Chicago, Illinois
  • +5 more
Jul 26, 2021

Ovarian Cancer Trial in United States (AVB-S6-500, Paclitaxel (Pac), Pegylated liposomal doxorubicin (PLD))

Active, not recruiting
  • Ovarian Cancer
  • Phoenix, Arizona
  • +15 more
Feb 16, 2022

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinosarcoma Trial in Germany, United Kingdom (Paclitaxel, TAK228)

Active, not recruiting
  • Ovarian Cancer
  • +9 more
  • Berlin, Germany
  • +14 more
Mar 10, 2022

Carcinosarcoma, Ovarian, Carcinosarcomas Uterine Trial in Rome (Trabectedin)

Completed
  • Carcinosarcoma, Ovarian
  • Carcinosarcomas Uterine
  • Rome, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Aug 24, 2021

Epithelial Ovarian Cancer Trial in Amsterdam (MK-1775 and carboplatin)

Active, not recruiting
  • Epithelial Ovarian Cancer
  • MK-1775 and carboplatin
  • Amsterdam, Netherlands
    Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Dec 21, 2021

Ovarian Cancer Recurrent Trial in Czechia (DCVAC/OvCa, Standard of Care Chemotherapy)

Completed
  • Ovarian Cancer Recurrent
  • DCVAC/OvCa
  • Standard of Care Chemotherapy
  • Brno, Czechia
  • +7 more
Apr 20, 2021

Recurrent Ovarian Cancer Trial in London (Nuc-1031 and Carboplatin)

Completed
  • Recurrent Ovarian Cancer
  • Nuc-1031 and Carboplatin
  • London, United Kingdom
    Garry Weston Cancer Centre, Hammersmith Hospital
May 17, 2021